Cytosorbents Corp (CTSO) – cijena dionice i vijesti

Simboli Simboli	Cijena	Promjena	Postotna promjena	Trend	Prethodna zadnja	Otvori	Najviša	Najniža	Količina	Trž. kap.
SIXB Materials SIXB Materials	SIXB +0,25%	1.104,10	+2,73	+0,25%	—	1.101,37	1.103,63	1.105,31	1.091,41	—	—
SIXC Communications SIXC Communications	SIXC −1,50%	604,16	−9,19	−1,50%	—	613,35	613,35	613,35	601,49	—	—
SIXE Energy SIXE Energy	SIXE −0,09%	1.197,81	−1,02	−0,09%	—	1.198,83	1.199,68	1.199,75	1.182,41	—	—
SIXI Industrials SIXI Industrials	SIXI −0,88%	1.740,41	−15,54	−0,88%	—	1.755,95	1.754,06	1.756,03	1.734,69	—	—
SIXM Financials SIXM Financials	SIXM −0,64%	634,44	−4,07	−0,64%	—	638,51	637,41	637,41	633,05	—	—
SIXR Staples SIXR Staples	SIXR −0,31%	840,90	−2,62	−0,31%	—	843,52	843,35	846,40	837,93	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,38%	215,13	−0,82	−0,38%	—	215,95	215,95	216,84	215,06	—	—
SIXT Technology SIXT Technology	SIXT +2,86%	3.228,71	+89,80	+2,86%	—	3.138,91	3.189,30	3.230,85	3.174,76	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	935,87	+1,50	+0,16%	—	934,37	934,72	938,26	927,50	—	—
SIXV Health care SIXV Health care	SIXV −1,37%	1.457,12	−20,31	−1,37%	—	1.477,43	1.474,12	1.474,12	1.451,80	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,83%	2.399,84	+19,65	+0,83%	—	2.380,19	2.389,34	2.403,04	2.380,47	—	—

CTSO:NASDAQ

Cytosorbents Corp

0,63 USD

−3,04%

(−0,020) 1D

24. tra, 16:00:01 GMT -4 · USD

Svi simboli

GDD

MAKS

	Simbol	Cijena	Promjena	Postotna promjena

Generiranje najvažnijih uvida za CTSO...

Otvori

0,64 USD

Najviša

0,65 USD

Najniža

0,62 USD

Trž. kap.

39,26 mil.

Prosj. kol.

99,75 tis.

Količina

22,06 tis.

52-tjed. najviša

1,39 USD

52-tjed. najniža

0,50 USD

EPS

−0,13 USD

Beta

1,47

Dionice u optjecaju

62,80 mil.

Broj djelatnika

129

Povezane dionice

BioXcel Therapeutics Inc

1,06 USD

−3,64%

Vijesti

Iz izvora na cijelom webu

Simply Wall Street

prije 2 minute

A Look At Kaspi.kz (NasdaqGS:KSPI) Valuation After Strongly Oversubscribed Investment Grade Bond Issue

AOL.com

prije 43 minute

The Stock Market Just Did Something It Hasn't Done Since 1999. History Has a Clear Answer.

MarketBeat

prije 50 minuta

Fastenal Company (NASDAQ:FAST) to Issue $0.24 Quarterly Dividend

Seeking Alpha

prije 1 sat

Nasdaq: My Multiple Target Has Been Reached, So I Am Upgrading To A Buy (NASDAQ:NDAQ)

Profil

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey. CytoSorbents sells a cytokine adsorbing column — a blood purification technology based on porous polymer beads that act like sponges in an attempt to remove harmful inflammatory mediators like Cytokines, Bilirubin, Myoglobin from the blood. The use of hemoperfusion columns is generally limited to patients who are critically ill in high-resource counties, and they require a patient to be connected to a hemofiltration system such as Dialysis, Hemofiltration Cardiopulmonary bypass or ECMO. Other blood purification devices are using different technologies with different performance parameters. This is including polymyxin B hemoperfusion columns, which failed to show significance in a clinical trial for sepsis. The CytoSorb technology has actually the largest body of clinical data confirming safety and efficacy. Clinicaltrials.gov is giving an overview over running research projects. CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins. Wikipedia

Cytosorbents Corp – informacije

Glavni izvršni direktor-

Zaposlenici129

Osnovano1997

Sjedište-

Sektor-

Web-lokacijacytosorbents.com

Sve vrijednosti su u valuti USD	ožu 2025.	lip 2025.	ruj 2025.	pro 2025.
Prihod	8,73 mil.	9,62 mil.	9,48 mil.	9,23 mil.
Trošak prodane robe	2,52 mil.	2,80 mil.	2,82 mil.	2,43 mil.
Trošak prihoda	2,52 mil.	2,80 mil.	2,82 mil.	2,43 mil.
Izdaci za istraživanje i razvoj	1,66 mil.	1,26 mil.	918,00 tis.	1,24 mil.
Ukupni izdaci za istraživanje i razvoj	-	-	-	-
Izdaci za prodaju, opći i administrativni izdaci	8,43 mil.	9,17 mil.	8,41 mil.	9,61 mil.
Poslovni rashod	10,09 mil.	10,43 mil.	9,33 mil.	10,86 mil.
Ukupni poslovni rashodi	12,61 mil.	13,23 mil.	12,15 mil.	13,28 mil.
Poslovni prihod	−3,89 mil.	−3,62 mil.	−2,66 mil.	−4,05 mil.
Ostali neposlovni prihod	-	-	-	-
Zarada prije poreza uključujući neuobičajene stavke	−1,48 mil.	1,95 mil.	−3,57 mil.	−5,50 mil.
Zarada prije poreza isključujući neuobičajene stavke	−1,48 mil.	1,95 mil.	−3,37 mil.	−4,60 mil.
Izdaci za porez na dohodak	-	-	−401,00 tis.	-
Efektivna porezna stopa	-	-	11,23 %	-
Ostali poslovni rashodi	-	-	-	-
Neto dohodak	−1,48 mil.	1,95 mil.	−3,17 mil.	−5,50 mil.
Neto profitna marža	−16,94 %	20,25 %	−33,42 %	−59,53 %
Zarada po dionici	-	-	-	-
Prihod od kamata i ulaganja	-	-	-	-
Izdaci za kamate	−605,13 tis.	−616,00 tis.	−645,00 tis.	−746,00 tis.
Neto izdaci za kamate	−605,13 tis.	−616,00 tis.	−645,00 tis.	−746,00 tis.
Troškovi amortizacije i otpisa	-	-	-	-
Dobit prije kamata, poreza i amortizacije	−3,52 mil.	−3,21 mil.	−2,30 mil.	−3,69 mil.
Dobit ili gubitak od prodaje imovine	-	-	-	-

AI sadržaj može uključivati pogreške. Saznajte više

PomoćPošaljite povratne informacijePrivatnost Uvjeti Odricanje od odgovornosti

Finance

Istraživanje